Product Information

MELOXICAM 10 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $10.7615 per EA under NDC 70954007710. Its NADAC has been published 139 times since Mar 20, 2024.

FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Meloxicam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MELOXICAM 10 MG CAPSULE

Meloxicam
$10.7615per EA
High Outlier

Strength

10 mg/1

NDC

70954007710

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MELOXICAM

Approval Type

Generic (ANDA)

FDA Application

ANDA211398

FDA Approved

3/9/2021

TE Code

AB

On Market Since

3/10/2021

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for MELOXICAM 10 MG CAPSULE has been published 139 times since Mar 20, 2024, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.

Current price$10.7615 per EA
All-time high$15.9668 (Apr 10, 2024)
All-time low$9.3007 (Oct 22, 2025)
52-week high$11.2463
52-week low$9.3760
Median price$10.7615
Average price$10.9777
Largest weekly change-17.1% (Apr 17, 2024)
Weeks tracked139
Tracking sinceMar 20, 2024

Price History

1W

0.0%

1M

-4.3%

3M

-3.4%

6M

+1.7%

1Y

+15.7%

3Y

N/A

5Y

N/A

All

-32.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MELOXICAM 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 10 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $10.7615 per EA (NDC 70954007710), effective Nov 11, 2026.

How has the price of MELOXICAM 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MELOXICAM 10 MG CAPSULE has declined 32.6%. It has been tracked across 139 weekly CMS publications since Mar 20, 2024.

What are the highest and lowest recorded NADAC prices for MELOXICAM 10 MG CAPSULE?

Since Mar 20, 2024, the NADAC for MELOXICAM 10 MG CAPSULE has ranged from a low of $9.3007 (Oct 22, 2025) to a high of $15.9668 (Apr 10, 2024), with a median of $10.7615 per EA.

Are there cheaper alternatives to MELOXICAM 10 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MELOXICAM 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures MELOXICAM 10 MG CAPSULE?

MELOXICAM 10 MG CAPSULE (NDC 70954007710) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.